Scientific Research Barriers by Gender and Other Characteristics in Physiatry

July 7, 2023 updated by: Mustafa Hüseyin Temel, Uskudar State Hospital

Evaluating Scientific Research Barriers by Gender and Other Characteristics From the Perspective of Physiatrists in Turkey: A Multicenter Survey Study

The ever-increasing population and life expectancy worldwide lead to a higher prevalence of physical disabilities and diseases, which increases the need for physical medicine and rehabilitation research. In our study, we aimed to evaluate various aspects of the barriers, particularly gender disparities, faced by physical medicine and rehabilitation professionals who wish to conduct scientific research.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Physicians in physical medicine and rehabilitation must also put in tremendous effort and manage their time meticulously to contribute to scientific research (SR). Research requires knowledge, experience, and institutional support, such as financial incentives, technical facilities, and trained personnel. In this field, research productivity is increasingly important due to the rising prevalence of conditions such as age-related disability and chronic pain, which put pressure on the healthcare system and affect people's quality of life. Turkey's publication productivity in physical medicine and rehabilitation has also increased steadily in recent years, with a significant number of articles published between 2015 and 2020. However, gender disparities in academic leadership positions persist in this field as well, with women lagging behind men in the number of scientific publications. While bibliometric studies are useful for assessing the current state of scientific performance, survey studies are necessary to identify obstacles that deter researchers and increase research productivity. Unfortunately, few studies have used this approach in physical medicine and rehabilitation, and no such study has been conducted in Turkey.

Study Type

Observational

Enrollment (Actual)

254

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Üsküdar
      • Istanbul, Üsküdar, Turkey, 34000
        • Uskudar State Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Physical medicine and rehabilitation physicians who consented to participate in the study.

Description

Inclusion Criteria:

  • Being a physical medicine and rehabilitation physician.
  • Giving consent to participate in the study.

Exclusion Criteria:

- Not giving consent to participate in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Physical Medicine and Rehabilitation Specialists
Physical medicine and rehabilitation specialists
This scale was prepared after a detailed literature review and sent to five physiatrists for review and feedback. It consists of 21 items with Likert-type responses and two open-ended questions. It is designed to measure the barriers that individuals or groups face in conducting research. The scale includes a list of potential barriers and asks respondents to rate the extent to which they experience each barrier. Examples of barriers that may be included in such a scale could include lack of funding, limited access to resources or equipment, time constraints, difficulty finding participants or accessing data, institutional or administrative hurdles, and so on.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Research Barriers Scale
Time Frame: 1 day
This scale was prepared after a detailed literature review and sent to five physiatrists for review and feedback. It consists of 21 items with Likert-type responses and two open-ended questions. It is designed to measure the barriers that individuals or groups face in conducting research. The scale includes a list of potential barriers and asks respondents to rate the extent to which they experience each barrier. Examples of barriers that may be included in such a scale could include lack of funding, limited access to resources or equipment, time constraints, difficulty finding participants or accessing data, institutional or administrative hurdles, and so on.
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mustafa H Temel, M.D., Uskudar State Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2023

Primary Completion (Actual)

June 15, 2023

Study Completion (Actual)

June 15, 2023

Study Registration Dates

First Submitted

April 6, 2023

First Submitted That Met QC Criteria

April 6, 2023

First Posted (Actual)

April 19, 2023

Study Record Updates

Last Update Posted (Actual)

July 10, 2023

Last Update Submitted That Met QC Criteria

July 7, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Barrier1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

IPD will be shared upon reasonable request by the principal investigator.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gender Bias

Clinical Trials on Research Barriers Scale

3
Subscribe